What is the pattern of recurrence in adrenocortical carcinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pattern of Recurrence in Adrenocortical Carcinoma

Adrenocortical carcinoma recurs in approximately 64-70% of patients after curative-intent resection, with the majority of recurrences occurring within the first 2 years, particularly within the first 11-18 months post-resection. 1, 2

Temporal Pattern of Recurrence

The greatest frequency of disease recurrence occurs within the first 2 years after surgery, which is why adjuvant mitotane is recommended for at least 2 years in high-risk patients 3. The median recurrence-free interval after primary resection is approximately 11 months, though this varies significantly based on tumor characteristics and site of recurrence 1.

  • Few ACC recurrences occur after 5 years, which is why continuing adjuvant mitotane beyond 5 years is not advised 3
  • The shortest time to recurrence is associated with lung metastases or multiple site metastases 1

Spatial Pattern of Recurrence

Initial Recurrence Sites

The most common sites of initial recurrence are the lungs and the tumor bed (locoregional) 1. Among patients who experience recurrence:

  • Distant-only recurrence: 45.1% of recurrent cases 2
  • Locoregional-only recurrence: 36.3% of recurrent cases 2
  • Combined locoregional and distant recurrence: 18.6% of recurrent cases 2

Systemic Recurrence Patterns

Systemic recurrence most often involves the liver, lungs, and bone 4. When distant metastases occur, they frequently involve multiple organs 1.

Sequential Recurrence Pattern

Recurrence is often a sequential process rather than a single event:

  • Of patients who develop initial recurrence, 57% (142 of 249) develop one or more additional sites of recurrence, with a median time of 5 months between first and second recurrence 1
  • The lungs are the most common site for subsequent recurrences 1
  • A subset of patients (20 in one series) develop a third site of recurrence 1

Risk Factors for Different Recurrence Patterns

Locoregional Recurrence Risk Factors

Left-sided ACC location (OR 2.71) and T3/T4 disease (OR 3.04) are associated with increased locoregional recurrence 2.

Distant Recurrence Risk Factors

Larger tumor size (OR 1.11 per cm) and T3/T4 disease (OR 5.23) are associated with distant recurrence 2.

Prognostic Implications by Recurrence Pattern

The pattern of recurrence significantly impacts survival:

  • Locoregional-only recurrence: Best prognosis with 3-year survival of 81.4% and 5-year survival of 64.1% 2
  • Distant-only recurrence: Intermediate prognosis with 3-year survival of 55.1% and 5-year survival of 43.3% 2
  • Combined locoregional and distant recurrence: Worst prognosis with 3-year survival of 39.5% and 5-year survival of 19.7% 2

Recurrences to the peritoneal cavity or to multiple sites are associated with worse survival compared to lung metastases, despite lung metastases occurring earlier 1.

Clinical Implications for Surveillance

Based on the temporal pattern of recurrence, radiological imaging should be performed:

  • Every 3 months for the first 2 years after complete resection 3
  • Every 3-6 months for at least another 3 years (years 3-5) 3

This intensive surveillance schedule is justified because the highest risk period is within the first 2 years, and early detection of recurrence may allow for potentially curative repeat resection in selected patients 5.

Pattern After Repeat Resection

Among patients who undergo reoperation or metastasectomy, 79% experience recurrence again 1. Importantly, same organ or site recurrence is common after reoperation, occurring in 67% of cases 1. This high rate of same-site recurrence suggests that microscopic disease often remains despite apparently complete resection.

Metastasectomy beyond three total operations does not improve overall survival, indicating diminishing returns with repeated surgical interventions 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.